Literature DB >> 22352725

Editorial: Antidotes and rescue therapies.

Richard Y Wang, Ziad N Kazzi.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22352725      PMCID： PMC4540176          DOI： 10.2174/138920112802273164

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN： 1389-2010            Impact factor:   2.837


× No keyword cloud information.
  29 in total

1.  1998 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

Authors:  T L Litovitz; W Klein-Schwartz; E M Caravati; J Youniss; B Crouch; S Lee
Journal:  Am J Emerg Med       Date:  1999-09       Impact factor: 2.469

2.  2000 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

Authors:  T L Litovitz; W Klein-Schwartz; S White; D J Cobaugh; J Youniss; J C Omslaer; A Drab; B E Benson
Journal:  Am J Emerg Med       Date:  2001-09       Impact factor: 2.469

3.  2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

Authors:  William A Watson; Toby L Litovitz; George C Rodgers; Wendy Klein-Schwartz; Jessica Youniss; S Rutherfoord Rose; Douglas Borys; Mary E May
Journal:  Am J Emerg Med       Date:  2003-09       Impact factor: 2.469

4.  2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

Authors:  William A Watson; Toby L Litovitz; George C Rodgers; Wendy Klein-Schwartz; Nicole Reid; Jessica Youniss; Anne Flanagan; Kathleen M Wruk
Journal:  Am J Emerg Med       Date:  2005-09       Impact factor: 2.469

5.  1997 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

Authors:  T L Litovitz; W Klein-Schwartz; K S Dyer; M Shannon; S Lee; M Powers
Journal:  Am J Emerg Med       Date:  1998-09       Impact factor: 2.469

6.  1995 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

Authors:  T L Litovitz; L Felberg; S White; W Klein-Schwartz
Journal:  Am J Emerg Med       Date:  1996-09       Impact factor: 2.469

7.  Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.

Authors:  S M Swain; F S Whaley; M C Gerber; S Weisberg; M York; D Spicer; S E Jones; S Wadler; A Desai; C Vogel; J Speyer; A Mittelman; S Reddy; K Pendergrass; E Velez-Garcia; M S Ewer; J R Bianchine; R A Gams
Journal:  J Clin Oncol       Date:  1997-04       Impact factor: 44.544

8.  2009 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 27th Annual Report.

Authors:  Alvin C Bronstein; Daniel A Spyker; Louis R Cantilena; Jody L Green; Barry H Rumack; Sandra L Giffin
Journal:  Clin Toxicol (Phila)       Date:  2010-12       Impact factor: 4.467

9.  Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial.

Authors:  R Keays; P M Harrison; J A Wendon; A Forbes; C Gove; G J Alexander; R Williams
Journal:  BMJ       Date:  1991-10-26

10.  Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer.

Authors:  J L Speyer; M D Green; E Kramer; M Rey; J Sanger; C Ward; N Dubin; V Ferrans; P Stecy; A Zeleniuch-Jacquotte
Journal:  N Engl J Med       Date:  1988-09-22       Impact factor: 91.245
View more
  3 in total

1.  National audit of antidote stocking in UK emergency departments.

Authors:  James T Harnett; Sheena Vithlani; Shabnam Sobhdam; James Kent; Lindsay McClure; Simon Hl Thomas; Paul I Dargan
Journal:  Eur J Hosp Pharm       Date:  2019-07-13

2.  Antidotes in Poisoning.

Authors:  Binila Chacko; John V Peter
Journal:  Indian J Crit Care Med       Date:  2019-12

Review 3.  An Appraisal of Antidotes' Effectiveness: Evidence of the Use of Phyto-Antidotes and Biotechnological Advancements.

Authors:  Christiana Eleojo Aruwa; Yusuf Ola Mukaila; Abdulwakeel Ayokun-Nun Ajao; Saheed Sabiu
Journal:  Molecules       Date:  2020-03-26       Impact factor: 4.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.